Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

28 Nov, 2018, 22:45 GMT Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence

Camurus announced today that the Australian Therapeutic Goods Administration (TGA) has approved the company's lead products Buvidal® Weekly and...


28 Nov, 2018, 21:00 GMT Adagio Medical's Persistent Atrial Fibrillation Cryoablation Study Demonstrates Early Single-Treatment Results Superior To Ablation Devices Requiring Two Procedures

Adagio Medical, Inc., developer of the iCLAS™ technology, the company's ultra-low temperature intelligent continuous lesion ablation system for the...


28 Nov, 2018, 12:31 GMT New Data Indicate That EyeMax Mono, a Lens Tailored Specifically for Patients With Dry Age-related Macular Degeneration (AMD), Offers Significant Improvement in Visual Function

EyeMax Mono implantation results in an improved mean visual acuity of 18 ETDRS letters and 57% increase in mean reading speed LEH Pharma Ltd, a...


28 Nov, 2018, 11:14 GMT CanImguide Therapeutics: New Discoveries in Cancer Related Immunosuppression are Paving the way for an Entirely new Immunotherapeutic Strategy

Cancer immunotherapy – the treatment approach that utilizes and enhances the power of the immune system - looks promising. Alternative or...


28 Nov, 2018, 11:00 GMT Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, presented...


28 Nov, 2018, 08:02 GMT Cyxone Concludes T20K's Preclinical Program Following Positive Results in Toxicology Studies

Cyxone (publ) announced today that the preclinical program for drug candidate T20K in multiple sclerosis (MS) has been concluded following positive...


28 Nov, 2018, 06:20 GMT Targovax is Invited to Present at Upcoming Investor and Industry Conferences

Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that...


27 Nov, 2018, 15:43 GMT Winner of Fresenius Kabi's Clinical Nutrition Research Grant Latin America to Begin Study on Omega-3 Fatty Acids

Besting more than 50 research study applications, medical researcher Dr. Aurora Serralde Zúñiga's entry on the study of omega-3 fatty acids in...


27 Nov, 2018, 13:00 GMT Daiichi Sankyo and Roche to Collaborate on New HER2 Low Companion Diagnostic Test

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that it has entered into an agreement with Roche to collaborate on the...


27 Nov, 2018, 12:00 GMT Roche launches first IVD pan-TRK immunohistochemistry assay

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch of the VENTANA pan-TRK (EPR17341) Assay, the first automated in vitro diagnostic ...


27 Nov, 2018, 09:18 GMT INC-Funded Study Announces New Scientific Evidence Suggesting Nuts May Help Improve Sperm Quality

WATCH THE VIDEO: https://youtu.be/RxtNlABLbqc Infertility is a major clinical concern, affecting 15% of all reproductive-age couples. Pollution,...


27 Nov, 2018, 07:00 GMT Mayoly Spindler: New Study Shows Test & Treat Strategy Using Urea Breath Tests Is Cost-effective in Managing Symptoms and Consequences From Infection Caused by the Helicobacter Pylori Bacteria, Contributing to Prevent Peptic Ulcer and Gastric Cancer

Helicobacter pylori infection is a major public health issue affecting 60% of the world's population with 90% of Peptic Ulcers attributed to and 80%...


26 Nov, 2018, 13:30 GMT Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) today announced that all patients had completed participation in its Phase 3, multinational, multicenter ...


26 Nov, 2018, 12:15 GMT CannTrust Ships CBD Oil Capsules to Gold Coast University for Clinical Trial on Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease (MND)

CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX: TRST), one of Canada's leading and most trusted licensed producers of cannabis,...


26 Nov, 2018, 12:15 GMT CannTrust Ships CBD Oil Capsules to Gold Coast University for Clinical Trial on Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease (MND)

CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX: TRST), one of Canada's leading and most trusted licensed producers of cannabis,...


23 Nov, 2018, 10:36 GMT Dante Labs Adds Pharmacogenomic Analysis for 100+ Drugs on Amazon and for Black Friday Offer

International biotech company Dante Labs expanded its whole genome sequencing with a pharmacogenomic analysis that measures the reaction to more than ...


22 Nov, 2018, 19:26 GMT The European Commission Grants Camurus Marketing Authorisation for Weekly and Monthly Buvidal® for Opioid Dependence

Buvidal® is the first long-acting medicine approved in the EU for the treatment of opioid dependence in adults and adolescents Camurus announced...


22 Nov, 2018, 14:59 GMT The European Commission Grants Marketing Authorisation for Weekly and Monthly Buvidal® for Opioid Dependence

Buvidal® is the first long-acting medicine approved in the EU for the treatment of opioid dependence in adults and adolescents Camurus announced...


22 Nov, 2018, 11:15 GMT Camurus Receives EU Approval for Weekly and Monthly Buvidal® (CAM2038) for Opioid Dependence

Camurus announced today that the European Commission (EC) has approved weekly and monthly Buvidal® (prolonged release buprenorphine) for the...


22 Nov, 2018, 07:00 GMT FDA Grants Priority Review for Daiichi Sankyo's New Drug Application for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug...


21 Nov, 2018, 15:00 GMT Blueberry Therapeutics Limited Announce Positive Results from a Phase I/II Clinical Trial

Blueberry Therapeutics Limited ("Blueberry Therapeutics"), a modern drug discovery and development company committed to the development of innovative ...


20 Nov, 2018, 17:53 GMT Pilatus Comparator Solutions US Expansion

PCS Inc. Long Island US Facility fully licenced and operational As part of Pilatus Comparator Solutions' ongoing plans to strengthen its Global...


20 Nov, 2018, 08:00 GMT Asceneuron Initiates Neuroimaging Trial for Tau Modifier ASN120290

Major milestone in development of novel treatment for progressive supranuclear palsy and other tau-related dementias Asceneuron SA, an emerging...


15 Nov, 2018, 07:00 GMT Arix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound

Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that...


14 Nov, 2018, 13:00 GMT Dragonfly Therapeutics Announces Expansion of its Strategic Collaboration with Celgene, Doubling the Number of Programs and Including Targets for Solid Tumor Indications

Dragonfly Therapeutics, Inc. ("Dragonfly" or the "Company"), today announced it entered into a new agreement with Celgene Corporation and its...